Carole Nuechterlein
CIK: 0001665133
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Nuechterlein Carole
Nuechterlein Carole (SEC CIK 0001665133) files insider reports with the SEC as Director of Freenome, Inc. (FRNM) and Director of Aligos Therapeutics, Inc. (ALGS).
Signal8 holds 3 ownership filings by Nuechterlein Carole (1 Form 3, 2 Form 4), filed between Jun 26, 2025 and Jul 27, 2026. Those filings report 2 transactions, from Jun 25, 2025 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nuechterlein Carole's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Nuechterlein Carole
Other insiders filing for Freenome, Inc. (FRNM)
- Elliott Aaron Matthew, Chief Executive Officer
- Waksal Harlan, Officer
- Costello Ann Catherine, Director
- VAN OORT DOUGLAS M, Director
- Le Linh H., Chief Financial Officer
- PAKIANATHAN DEEPIKA, Director